Brimica® Genuair® (aclidinium bromide + eformoterol) listed on the PBS from 1 December 2015

Thursday, 3 Dec 2015

Brimica® Genuair® 340/12 is a twice daily LAMA/LABA maintenance bronchodilator treatment to relieve chronic obstructive pulmonary disease symptoms in adults.

The combination treatment contains eformoterol and aclidinium, the LAMA used in Bretaris® Genuair®.

About the dose

The recommended dose is one inhalation twice a day. Patients should be advised to take Brimica® Genuair® at the same times of the day every day e.g. 7 am and 7 pm.

About the device

Brimica® is available in the same 2-step Genuair® inhaler as Bretaris® Genuair®. It is pre-loaded and easy to use with multiple feedback mechanisms so that the patient knows the device has been used correctly.

Need more information?

Before prescribing, please review the full Product Information. The Product Information for Brimica® Genuair® 340/12 can be found here


Brimica PBS


Already a member?

Login to keep reading.

Email me a login link

© 2022 the limbic